Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 9.42 USD -7.56% Market Closed
Updated: Jun 2, 2024

Phathom Pharmaceuticals Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Phathom Pharmaceuticals Inc
Total Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Total Equity
-$72.8m
CAGR 3-Years
N/A
CAGR 5-Years
-124%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Equity
$70B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Total Equity
$16.5B
CAGR 3-Years
-24%
CAGR 5-Years
2%
CAGR 10-Years
1%
Pfizer Inc
NYSE:PFE
Total Equity
$92.3B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Total Equity
$40.4B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
-2%
Eli Lilly and Co
NYSE:LLY
Total Equity
$12.8B
CAGR 3-Years
23%
CAGR 5-Years
39%
CAGR 10-Years
-4%

See Also

What is Phathom Pharmaceuticals Inc's Total Equity?
Total Equity
-72.8m USD

Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Total Equity amounts to -72.8m USD.

What is Phathom Pharmaceuticals Inc's Total Equity growth rate?
Total Equity CAGR 5Y
-124%

Over the last year, the Total Equity growth was 3%.